Browse all 651 ETFs by category, no search needed
Global 185
US market 62
Country 93
Core UCITS 15
Sector 103
Style & factor 111
Theme 45
Dividend 37
Global X Aging Population (AGNG)Overvalued or undervalued?
Look-through valuation · Global · Expense ratio 0.50 % · ISIN US37954Y7720
Price history (since 2016)
Monthly close since 2016. Price shows performance, the valuation verdict is in the look-through above.
Top holdings
| Holding | Weight | vs fair value | Quality |
|---|---|---|---|
| AbbVie Inc ABBV | 3.6 % | −2.0 % | 73 |
| Eli Lilly and Company LLY | 3.6 % | −31.2 % | 69 |
| Merck & Company Inc MRK | 3.6 % | −12.8 % | 70 |
| Welltower Inc WELL | 3.3 % | −71.8 % | 42 |
| Johnson & Johnson JNJ | 3.3 % | −37.2 % | 80 |
| Edwards Lifesciences Corp EW | 3.2 % | −5.5 % | 67 |
| Amgen Inc AMGN | 3.2 % | +10.0 % | 63 |
| Roche Holding AG RO | 3.2 % | −12.6 % | 75 |
| Novo Nordisk A/S Class B 0QIU | 3.1 % | n/a | n/a |
| Bristol-Myers Squibb Company BMY | 3.1 % | +24.3 % | 80 |
| Medtronic PLC MDT | 3.1 % | −26.6 % | 68 |
| Regeneron Pharmaceuticals Inc REGN | 3.0 % | +56.1 % | 72 |
| Ventas Inc VTR | 3.0 % | −64.4 % | 41 |
| BeiGene Ltd BGNE | 2.7 % | n/a | n/a |
| Sandoz Group AG SDZ | 2.5 % | −43.3 % | 56 |
| AstraZeneca PLC AZN | 2.4 % | n/a | n/a |
| Stryker Corporation SYK | 2.4 % | +10.0 % | 68 |
| DexCom Inc DXCM | 2.3 % | +10.0 % | 82 |
| Chugai Pharmaceutical Co. Ltd. 4519 | 2.3 % | n/a | n/a |
| UCB SA UCB | 2.2 % | −15.5 % | 81 |
| Alcon AG ALC | 2.2 % | n/a | n/a |
| Celltrion Inc 068270 | 2.1 % | −58.0 % | 46 |
| Boston Scientific Corp BSX | 2.1 % | +10.0 % | 66 |
| Hansoh Pharmaceutical Group Co Ltd 3692 | 1.8 % | +14.8 % | 74 |
| Astellas Pharma Inc. 4503 | 1.8 % | n/a | n/a |
Fair value and quality per position come from the same valuation as our stock pages. Showing the 25 largest of 50 disclosed positions. "n/a" means the position is not (yet) in our stock universe and does not enter the average.
The 10 most cheaply valued ETFs
Measured against the look-through fair value of the holdings (sufficiently covered funds only). Green means below fair value, red above. Not financial advice.
- 1 CHIU Global X MSCI China Utilities ETF +87.2 % below FV
- 2 FXI iShares China Large-Cap ETF +57.2 % below FV
- 3 FCFY First Trust S&P 500 Diversified Free Cash Flow ETF +43.7 % below FV
- 4 MCHI iShares MSCI China ETF +41.9 % below FV
- 5 ITB iShares U.S. Home Construction ETF +31.4 % below FV
- 6 TAN Invesco Solar ETF +26.0 % below FV
- 7 C003 Amundi Index Solutions - Amundi DivDAX I UCITS ETF EUR Distributing +19.4 % below FV
- 8 FDNI First Trust Dow Jones International Internet ETF +19.3 % below FV
- 9 ESPO VanEck Video Gaming and eSports ETF +18.3 % below FV
- 10 XIDV Franklin International Dividend Booster Index ETF +17.9 % below FV
Frequently asked about AGNG
Is AGNG overvalued?
What is the fair value of AGNG?
How do you calculate the fair value of an ETF?
Which stocks drive the valuation of AGNG?
What is the expense ratio of AGNG?
How we value this ETF
An ETF has no fair value of its own like a single stock. We build it bottom up: every holding has a fair value and a quality score on our pages. Weighted by portfolio share, that gives Global X Aging Population ETF an average of how cheap or expensive its companies currently sit versus fair value, and how high their average quality is.
As of: Sep 25, 2026
The look-through is a computed summary of public fundamentals and is no substitute for your own research.